V Dimov, N Ivanovska, N Manolova, V Bankova, N Nikolov, et al.. Immunomodulatory action of propolis. Influence on anti-infectious protection and macrophage function. Apidologie, Springer Verlag, 1991, 22 (2), pp.155-162. hal-00890904 Summary &mdash; The immunomodulatory action of a water-soluble derivative (WSD) of natural propolis was investigated. The oral and parenteral administration of the WSD enhanced the survival rate and the mean survival time in experimental bacterial (Klebsiella pneumoniae, Staphyllococcus aureus) and fungal (Candida albicans) infections in mice. An increased resistance was observed also in Klebsiella pneumoniae infection induced after cyclophosphamide treatment. The WSD stimulated peritoneal macrophages to produce in vitro interleukin-1, which corresponded to their elevated total protein secretion. In addition, WSD failed to trigger lymphocyte proliferation as determined by popliteal lymph node assay. The WSD was suggested to augment non-specific host defense via macrophage activation.
INTRODUCTION
Honey bee products have been used in modern clinics, especially in the treatment of infections and allergic and inflammatory states (Pochinkova, 1986) . Propolis is an effective remedy, exerting antiviral and antimicrobial activities , Up to now, more than 100 compounds, mainly polyphenols, have been identified as constituents of propolis col-lected in different regions. The major polyphenols are flavonoid aglycones, accompanied by phenolic acids and their esters, phenolic aldehydes, ketones, etc (Ghisalberti, 1979 ; Bankova and Marekov, 1984; Walker and Crane, 1987; Greenaway et al, 1989) .
Anti-infectious drugs such as antibiotics or antivirals have begun to exhaust their therapeutic capabilities. The widespread occurrence of disfunctions of the immune * Correspondence and reprints system requires new approaches. Immunomodulation through natural or synthetic substances may be considered an alternative for the prevention and cure of infectious diseases (Azuma and Jolles, 1987; Hadden et al, 1989; Toshkov et al, 1989 ). All known drugs and medicines based on natural propolis contain only its nonsoluble forms. Some of these oral preparations, like Aagard propolis (NF Borner, Germany), exert general biostimulation but their influence on the immune system has not been studied. A number of newly found propolis derivatives have been reported to inhibit viral replication in vitro and in vivo and to increase resistance against viral infections. These recently developed water-soluble fractions and forms of natural propolis can be applied both orally and parenterally, and having a better resorbtion, they are believed to possess an improved efficacy (Manolova et al, , 1986 Maximova-Todorova et al, 1985; König and Dustmann, 1986) .
The present study investigated the properties of one of the propolis forms, named water-soluble derivative (WSD), related to antibacterial and antifungal protection, and cellular mechanisms of action.
MATERIALS AND METHODS

Water-soluble derivative (WSD) treatment
The water-soluble derivative (WSD) was obtained according to the protocol of Nikolov et al (1987) . Ten WSD specimens from different propolis samples collected in several geographical areas of Bulgaria were prepared. The differences between their chemical compositions were insignificant as detected by highperformance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) (Bankova et al, 1982 Bankova and Kuleva, 1989) . Freeze-dried WSD was dissolved in distilled water at different concentrations and solutions were administered in various schemes (tables I-IV) to male and female inbred mice (ICR strain) 18-20 g bw.
Experimental infections
Bacterial and fungal infections in WSD-treated and nontreated (control) mice were induced with: -Klebsiella pneumoniae, strain 52145 (Institute Pasteur, Paris) at a dose of 25-30 cells per mouse, sc; -Staphylococcus aureus, strain Smith (Institute of Microbiology, Sofia) at a dose of 2 x 10 9 cells per mouse, iv; -Candida albicans, strain 562 (Institute of Infectious and Parasitic Diseases, Sofia) at a dose of 2 x 10 9 cells per mouse, iv.
The doses for inoculation were chosen after preliminary experiments to achieve a survival rate of &ap; 30-40%. The course of infections were followed up to the 8th, 15th and 30th d after inoculation with KI pneumoniae, S aureus and C albicans, respectively. The survival rate (S) and mean survival time (MST) were calculated. The effect of WSD was expressed as a difference (&Delta;) in S or MST of WSD-treated and control groups.
Immunosuppressive drug regimen
The cyclophosphamide, Cy (Germed, Germany), was injected at different intervals prior to inoculation with KI pneumoniae as described (see footnotes to table II).
Macrophage cultures
At the 5th, 7th, 15th and 20th d after treatment with WSD, peritoneal macrophages were obtained by a single washing of peritoneal cavity with 10 ml of tissue medium RPMI 1640 supplemented with 20 mM HEPES, 100 &mu;g/ml streptomycin and 100 U/ml penicillin (Flow Lab, UK).
Cell suspensions in concentration of 2 x 10 6 /ml were plated on 16-mm diameter wells (Nunc, Denmark).
IL-1 activity assay
The level of IL-1 in the 24-h macrophage supernatants was determined by augmentation of 3 H-thymidine incorporation by mouse thymocytes (Meltzer and Oppenheim, 1977) . Briefly, single cell suspensions of thymuses from ICR mice (1.0 x 10 6 cells in 0.1 ml) were cultured with 0.1 ml of the macrophage supernatants at 1:4 dilution for 40 h in a 96-well microtissue culture plate. The culture medium contained a submitogenic concentration (1 &mu;g/ml) of phytohaemagglutinin, PHA (Sigma, USA) and 2.5 x 10 -5 M 2-mercaptoethanol (Merck, Germany). Thymic cultures were pulsed for 6 h with 1 &mu;Ci of 3 Hthymidine (Amersham, UK).
Total protein secretion measurement
A portion of macrophages was cultured in the presence of 1 &mu;Ci/ml 14 C-glycine (Amersham). After 24 h the radiolabelled proteins were counted.
Popliteal lymph node (PLN) assay
A single dose of WSD was injected into the right hind footpad leaving the contralateral side unin-jected as a control, according to the method of Gleichmann (1981) . The popliteal lymph nodes were removed at different intervals and weighed immediately. The effect of WSD to ensure PLN reaction was expressed as PLN index being the ratio of the lymph node weights of the injected over the uninjected side.
RESULTS AND DISCUSSION
The pretreatment with WSD induced protection against the model infection, although the pathogens challenged different processes: lethal pneumonia, toxic septicemia, disseminated mycosis after KI pneumoniae, S aureus and C albicans, respectively (table I) . Better protective effect of the preparation emerged in the case of KI pneumoniae infection as compared to another bacterial infection. The mortality rate in the course of C albicans infection was relatively low. Previous data and present investigation suggest that propolis stimulates macrophages and enhances survival, because the macrophages are assumed to be the major factor preventing bacterial and fungal dissemination .
In addition to its immunostimulatory action in the case of infections induced in intact hosts, WSD showed an immunorestorative effect. Profound immunosupression developed as a result of cyclophosphamide injections (table II) . The infection in the immunocompromised host was strongly exacerbated as illustrated by negative A S 8 and &Delta; MST 8 . Simultaneous administration of WSD prevented drug-induced immunosuppression and improved survival.
Based on the antibacterial and antifungal effect of WSD, and the anti-influenzal action of some propolis fractions (Manolova et al, , 1986 Maximova-Todorova et al, 1985) we conclude that different propolis derivatives induce anti-infectious protection comparable to other immunostimulants (Azuma and Jolles, 1987; Hadden et al, 1988; Toshkov et al, 1989 ). The influence of some propolis fractions on specific and non-specific immune defense mechanisms, ie, the release of migration inhibitory factor, macrophage phagocytosis, numbers of rosette-forming and antibodyproducing cells, has been previously reported (Manolova et al, 1987; ). Since macrophages are required to provide anti-infectious defense, the influence of WSD on their function was established. The substance was found to stimulate macrophages to produce IL-1, which corresponded to enhanced protein secretion and was taken as a reference for macrophage activation (table III) . The WSD slowly and continuously elevated the IL-1 production during the entire observation period. These long-lasting consequences of WSD application coincided with the antiinfectious protection up to the 30th day. The peak of the IL-1 activity at the 20th day was similar to the effect of the other immunostimulants on macrophage activation (Toshkov et al, 1989) , and a connection with the metabolism of the agent should be investigated. A variety of immunostimulants, eg Lentinan (Yamanouchi Pharmaceutical Co, Japan), lipopolysaccharides, Broncho-Vaxom (Laboratories OM, Switzerland), chitin derivatives, and muramil dipeptide have been examined as potent in vivo or in vitro inducers of IL-1 in man and animals (Chihara, 1984; Kido et al, 1984;  Martin du Pan and Koechli, 1984; Nishimura et al, 1986; Oppenheim et al, 1980) . Their proven therapeutic capability is related to action on macrophages. In the case of infections and neoplasms, this action includes changes in IL-1 (a lymphocyte activating factor), which is highly involved in immune cell cooperation.
Additional evidence that the action of WSD may be limited mainly to macrophages was shown in the lack of influence on lymphocyte proliferation. The injection of WSD failed to trigger a significant reaction, as illustrated by kinetics of popliteal lymph node enlargement (table IV) . According to the detailed study of Gleichmann (1981) , T cells are believed to be required for genuine PLN reactions. In contrast to previous observations on the effect of some propolis fractions on antigen-binding cells , PLN non-responsiveness to the various WSD doses argues against the possibility that the agent acts as a mitogen on lymphocytes. The present experiments also suggest that WSD is incapable of inducing sensitization, thus mediating a proper effect through macrophages. The effect of similar propolis preparations on B lymphocytes is shown by augmentation of the number of plaque-forming cells and spleen weight index Scheller et al, 1988) . Based on the results presented here, we postulate that the broad therapeutic spectrum of propolis includes a pronounced immunomodulatory activity directed mainly toward augmenting non-specific anti-infectious resistance via macrophage activation. The exact mechanisms underlying the induced protection remain obscure.
Résumé -Action immunomodulatrice de la propolis. Influence sur la protection anti-infectieuse et la fontion macrophage. Ce travail étudie l'action de dérivés hydrosolubles (WSD) de la propolis sur la défense de l'organisme contre l'infection et les réactions immunes. Des solutions à diverses concentrations de WSD lyophylisés de propolis ont été préparées stérilement.
Elles ont été administrées par voie orale ou par injections intrapéritonales ou souscutanées à des souris consanguines (souche ICR), à des doses allant de 50 à 150 mg par kg, durant 3 j consécutifs avant l'inoculation de bactéries (Klebsiella pneumoniae et Staphylococcus aureus) ou de champignon (Candida albicans). On a calculé le taux de survie (S) et le temps moyen de survie (MST) à la fin du développement des infections modèles (8, 15 ou 30 j respectivement). L'action des WSD a été estimée d'après les différences (&Delta;) du S (%) et du MST (j) entre des souris traitées aux WSD et des souris non traitées (témoins). En général, le prétraitement aux WSD a suscité une protection maximale meilleure (tableau I) dans le cas de l'infection par KI pneumoniae (+ 60,0%; + 1,2 j). L'effet bénéfique des WSD a été également élevé dans le cas de l'infection fongique (+ 62,5%; + 17,0 j). En outre, la substance a restauré la réponse immunitaire dans le cas de l'infection par KI pneumoniae chez des organismes hôtes immunodéprimés par application de cyclophosphamide (tableau II).
Les WSD ont stimulé la production in vitro d'interleukine-1 (IL-1) par les macrophages péritonéaux. Cette production, exprimée en coups/min par l'incorporation de 3 H-thymidine par les thymocytes, a été maximale le 20 e j et correspond à la sécrétion accrue de protéines totales (tableau III). L'injection de WSD, à la dose de 3 mg dans la patte arrière droite, n'a pas réussi à déclencher la prolifération des lymphocytes des ganglions poplités (tableau IV).
Ceci peut être considéré comme une preuve supplémentaire que l'action des WSD est limitée principalement aux macrophages. Il est évident que la propolis et ses dérivés présentent une activité immunomodulatrice marquée, qui se traduit par un augmentation de la résistance non spécifique due à l'activation des macrophages. 
